Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].

Autor: Leung HW; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong., Lau EYT; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Leung CON; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong., Lei MML; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong., Mok EHK; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong., Ma VWS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Cho WCS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Ng IOL; Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong., Yun JP; Department of Pathology, Sun Yat Sen University Cancer Center, China., Cai SH; Department of Pathology, Sun Yat Sen University Cancer Center, China., Yu HJ; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Hong Kong., Ma S; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong., Lee TKW; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong; State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong. Electronic address: terence.kw.lee@polyu.edu.hk.
Jazyk: angličtina
Zdroj: Cancer letters [Cancer Lett] 2021 Feb 28; Vol. 499, pp. 2. Date of Electronic Publication: 2020 Jun 17.
DOI: 10.1016/j.canlet.2020.06.007
Databáze: MEDLINE